• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SPES/SCOPA 和 MDS-UPDRS:用于转换帕金森病两种运动量表评分的公式。

SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease.

机构信息

Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Parkinsonism Relat Disord. 2011 Sep;17(8):632-4. doi: 10.1016/j.parkreldis.2011.05.022. Epub 2011 Jun 22.

DOI:10.1016/j.parkreldis.2011.05.022
PMID:21696993
Abstract

BACKGROUND

Motor impairment in Parkinson's disease (PD) can be evaluated with the Short Parkinson's Evaluation Scale/Scales for Outcomes in Parkinson's disease (SPES/SCOPA) and the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The aim of this study was to determine equation models for the conversion of scores from one scale to the other.

METHODS

148 PD patients were evaluated with the SPES/SCOPA-motor and the MDS-UPDRS motor examination. Linear regression was used to develop equation models.

RESULTS

Scores on both scales were highly correlated (r = 0.88). Linear regression revealed the following equation models (explained variance: 78%):

CONCLUSION

With the equation models identified in this study, scores from SPES/SCOPA-motor can be converted to scores from MDS-UPDRS motor examination and vice versa.

摘要

背景

帕金森病(PD)的运动障碍可以用短帕金森评估量表/帕金森病结局量表(SPES/SCOPA)和运动障碍协会统一帕金森病评定量表(MDS-UPDRS)进行评估。本研究的目的是确定从一种量表到另一种量表的评分转换方程模型。

方法

148 例 PD 患者接受了 SPES/SCOPA-运动和 MDS-UPDRS 运动检查。线性回归用于建立方程模型。

结果

两种量表的评分高度相关(r=0.88)。线性回归显示以下方程模型(解释方差:78%):

结论

本研究确定的方程模型可将 SPES/SCOPA-运动评分转换为 MDS-UPDRS 运动检查评分,反之亦然。

相似文献

1
SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease.SPES/SCOPA 和 MDS-UPDRS:用于转换帕金森病两种运动量表评分的公式。
Parkinsonism Relat Disord. 2011 Sep;17(8):632-4. doi: 10.1016/j.parkreldis.2011.05.022. Epub 2011 Jun 22.
2
Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.左旋多巴急性冲击试验中运动障碍学会统一帕金森病评定量表(MDS-UPDRS)与帕金森病评定量表(UPDRS)的相关性。
Parkinsonism Relat Disord. 2011 Nov;17(9):705-7. doi: 10.1016/j.parkreldis.2011.07.002. Epub 2011 Jul 23.
3
Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.统一帕金森病评定量表和简短帕金森病评估量表的心理测量学特性。
Neurol Sci. 2003 Oct;24(3):190-1. doi: 10.1007/s10072-003-0124-0.
4
Unified Parkinson's disease rating scale motor examination: are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable?统一帕金森病评定量表运动检查:护士、神经内科住院医师和运动障碍专家的评分是否可互换?
Mov Disord. 2005 Dec;20(12):1577-84. doi: 10.1002/mds.20640.
5
A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA.一种用于评估帕金森病运动障碍和残疾程度的简短量表:SPES/SCOPA量表
J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):388-95. doi: 10.1136/jnnp.2003.017509.
6
Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part II, construct and content validity.统一帕金森病评定量表3.0套件的计量属性:第二部分,结构效度和内容效度。
Mov Disord. 2006 Nov;21(11):1892-8. doi: 10.1002/mds.21071.
7
SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease.SCOPA睡眠量表和帕金森病睡眠量表:两种评估帕金森病睡眠障碍的量表。
Mov Disord. 2008 Sep 15;23(12):1681-8. doi: 10.1002/mds.22110.
8
International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.帕金森病非运动症状量表心理测量属性的国际研究。
Neurology. 2009 Nov 10;73(19):1584-91. doi: 10.1212/WNL.0b013e3181c0d416.
9
[Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS): a new scale for the evaluation of Parkinson's disease].[运动障碍协会统一帕金森病评定量表(MDS-UPDRS):一种评估帕金森病的新量表]
Rev Neurol (Paris). 2010 Jan;166(1):1-4. doi: 10.1016/j.neurol.2009.09.001. Epub 2009 Nov 12.
10
The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease.早期帕金森病患者统一帕金森病评定量表与下肢功能表现之间的关系。
Neurorehabil Neural Repair. 2009 Sep;23(7):657-61. doi: 10.1177/1545968309332878. Epub 2009 Mar 31.

引用本文的文献

1
Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanisms.帕金森病性精神病中的视觉失配负波及测试治疗机制的潜力
Brain Commun. 2024 Sep 3;6(5):fcae291. doi: 10.1093/braincomms/fcae291. eCollection 2024.
2
Validity and reliability of the Italian version of the short Parkinson's evaluation scale (SPES/SCOPA).帕金森病简短评估量表意大利语版(SPES/SCOPA)的效度和信度。
Heliyon. 2024 Jun 12;10(12):e32877. doi: 10.1016/j.heliyon.2024.e32877. eCollection 2024 Jun 30.
3
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson's disease.
帕金森病丘脑底核刺激短期焦虑结局的预测因素
NPJ Parkinsons Dis. 2024 Jun 8;10(1):114. doi: 10.1038/s41531-024-00701-6.
4
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled Trial.神经刺激治疗晚期帕金森病与 5 年生活质量:一项非随机对照试验。
JAMA Netw Open. 2024 Jan 2;7(1):e2352177. doi: 10.1001/jamanetworkopen.2023.52177.
5
Parkinson's Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors.帕金森病:设备辅助治疗(DAT)的个性化护理路径以及可穿戴传感器在持续客观监测(COM)中的作用
J Pers Med. 2021 Jul 19;11(7):680. doi: 10.3390/jpm11070680.
6
Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease.帕金森病丘脑底核刺激术后36个月生活质量的非运动预测因素
NPJ Parkinsons Dis. 2021 Jun 8;7(1):48. doi: 10.1038/s41531-021-00174-x.
7
Determinants of generic and specific health-related quality of life in patients with Parkinson's disease.帕金森病患者一般和特定健康相关生活质量的决定因素。
PLoS One. 2017 Jun 26;12(6):e0178896. doi: 10.1371/journal.pone.0178896. eCollection 2017.
8
Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.利用临床基因评分预测帕金森病的认知功能:九个队列的纵向分析
Lancet Neurol. 2017 Aug;16(8):620-629. doi: 10.1016/S1474-4422(17)30122-9. Epub 2017 Jun 16.
9
Converting positive and negative symptom scores between PANSS and SAPS/SANS.将 PANSS 和 SAPS/SANS 的阳性和阴性症状评分进行转换。
Schizophr Res. 2014 Jan;152(1):289-94. doi: 10.1016/j.schres.2013.11.013. Epub 2013 Dec 11.
10
Lack of association of morphologic and functional retinal changes with motor and non-motor symptoms severity in Parkinson’s disease.帕金森病患者的形态和功能视网膜变化与运动和非运动症状严重程度缺乏关联。
J Neural Transm (Vienna). 2014 Feb;121(2):139-45. doi: 10.1007/s00702-013-1093-y.